Tamsulosin relief of ureteral stones

For the analysis of randomized controlled trials assessing the efficacy of tamsulosin in the treatment of ureteral stones was conducted a literature search using different databases.

Compared with the control group, the tamsulosin group noted an increased frequency of self-discharge of stones by 51% and reducing the time of origin of 2.63 days. In addition, tamsulosin reduced the risk of recurrence of renal colic with conservative therapy by 40% and the risk of additional interventions during follow-up to 60%. However, tamsulosin group showed an increase in adverse events at 117% compared with the control group, in particular vertigo.

Tamsulosin promotes discharge of ureteral stones, increasing the frequency of self-discharge, with a decrease in the required time and a lower incidence of recurrence of renal colic and additional interventions. However, the therapy is much more common in dizzy, concluded the study’s authors.